Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marta Toledano‐Fonseca
Observed names:
M. Toledano,
M. Toledano-Fonseca,
Marta Toledano,
Marta Toledano-Fonseca,
Toledano-Fonseca, Marta
Institutions:
Instituto Maimónides de Investigación Biomédica de Córdoba,
Hospital Universitario Reina Sofía,
Centro de Investigación Biomédica en Red de Cáncer,
University of Córdoba
Observed institutions:
Instituto de Salud Carlos III,
Instituto Maimónides de Investigación Biomédica de Córdoba,
Hospital Universitario Reina Sofía,
Roche (Spain),
Centro de Investigación Biomédica en Red de Cáncer,
University of Córdoba
show all 6
ORCID:
0000-0002-1997-9197
Observed ORCID:
0000-0002-1997-9197
OpenAlex ID:
A5058203357
Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection
2024
·
Elena Brozos-Vázquez
, Marta Toledano-Fonseca
, et al.
·
Cancer Treatment Reviews
·
59
Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer
2020
·
Marta Toledano-Fonseca
, M. Teresa Cano
, et al.
·
Cancers
·
59
PDF
Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples
2019
·
Ana Vivancos
, Enrique Aranda
, et al.
·
Scientific Reports
·
50
A role for endothelial nitric oxide synthase in intestinal stem cell proliferation and mesenchymal colorectal cancer
2018
·
Jon Peñarando
, Laura M. López-Sánchez
, et al.
·
BMC Biology
·
42
PDF
The Combination of Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer
2021
·
Marta Toledano-Fonseca
, M. Teresa Cano
, et al.
·
Cancers
·
39
Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects
2023
·
María Victoria García-Ortiz
, Pablo Cano-Ramírez
, et al.
·
Biomarker Research
·
38
PDF
Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer
2023
·
María Victoria García-Ortiz
, Pablo Cano-Ramírez
, et al.
·
Clinical Epigenetics
·
28
PDF
Association of Tumor Budding With Immune Evasion Pathways in Primary Colorectal Cancer and Patient-Derived Xenografts
2020
·
Silvia Guil-Luna
, Rafael Mena
, et al.
·
Frontiers in Medicine
·
23
PDF
Nitric oxide-targeted therapy inhibits stemness and increases the efficacy of tamoxifen in estrogen receptor-positive breast cancer cells
2020
·
Laura M. López-Sánchez
, Rafael Mena
, et al.
·
Laboratory Investigation
·
22
Clinical significance of glycogen synthase kinase 3 (GSK-3) expression and tumor budding grade in colorectal cancer: Implications for targeted therapy
2023
·
Silvia Guil-Luna
, Aurora Rivas-Crespo
, et al.
·
Biomedicine & Pharmacotherapy
·
19
SWATH‐based proteomics reveals processes associated with immune evasion and metastasis in poor prognosis colorectal tumours
2019
·
Laura M. López‐Sánchez
, Rafael Jiménez‐Izquierdo
, et al.
·
Journal of Cellular and Molecular Medicine
·
19
PDF
Unveilling the potential of liquid biopsy in pancreatic cancer for molecular diagnosis and treatment guidance
2025
·
Marta Toledano-Fonseca
, Elena Brozos-Vázquez
, et al.
·
Critical Reviews in Oncology/Hematology
·
13
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients
2023
·
M. Toledano-Fonseca
, M.A. Gómez-España
, et al.
·
Biomedicine & Pharmacotherapy
·
11
Metabolic shift underlies tumor progression and immune evasion in S‐nitrosoglutathione reductase‐deficient cancer
2023
·
Rafael Mena‐Osuna
, Ana Mantrana
, et al.
·
The Journal of Pathology
·
8
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial
2021
·
Elena Élez
, María Auxiliadora Gómez-España
, et al.
·
British Journal of Cancer
·
8
PDF
Basal VEGF-A and ACE Plasma Levels of Metastatic Colorectal Cancer Patients Have Prognostic Value for First-Line Treatment with Chemotherapy Plus Bevacizumab
2022
·
M. José Ortiz-Morales
, Marta Toledano-Fonseca
, et al.
·
Cancers
·
6
Glycolysis Inhibition Restores Immune Sensitivity in GSNOR–Deficient Colorectal Cancer
2025
·
Ana Mantrana
, María Teresa Sánchez-Montero
, et al.
·
Laboratory Investigation
·
3
Imbalanced NK cell subpopulations and TIGIT expression limit cetuximab efficacy in colorectal cancer: A promising target for treatment enhancement
2025
·
Carmen Navarrete‐Sirvent
, Ana Mantrana
, et al.
·
Clinical and Translational Medicine
·
3
PDF
Associations of blood RNA biomarkers and circulating tumour cells in patients with previously untreated metastatic colorectal cancer
2025
·
Manuel Valladares-Ayerbes
, Marta Toledano-Fonseca
, et al.
·
BMC Cancer
·
3
PDF
Kras mutation as a risk factor for venous thromboembolism in patients with metastatic pancreatic cancer.
2021
·
Elena Serrano
, Elizabeth Inga Saavedra
, et al.
·
Journal of Clinical Oncology
·
2
Evaluation of the sensitivity of RAS mutation detection of the Idylla platform in comparison to the OncoBEAM RAS CRC assay.
2018
·
Anna Vivancos
, Enrique Aranda
, et al.
·
Journal of Clinical Oncology
·
2
Update of mortality and incidence rates for intrahepatic cholangiocarcinoma and other hepatobiliary tumours in England & Wales
2005
·
Saeed Khan
, Kate Mandeville
, et al.
·
LSHTM Research Online (London School of Hygiene and Tropical Medicine)
·
2
Considering Tumour Sidedness is Critical for Accurate Interpretation of Liquid Biopsy Results in Metastatic Colorectal Cancer
2026
·
Marta Toledano-Fonseca
, Icíar de la Fuente
, et al.
·
Molecular Diagnosis & Therapy
PDF
NR3C1 , LAX1 , and RCAN3 as Circulating Epigenetic Biomarkers for Prognosis and Chemotherapy Response Prediction in Metastatic Pancreatic Cancer
2026
·
Pablo Cano‐Ramírez
, Marta Toledano‐Fonseca
, et al.
·
MedComm
Circulating hsa‐miR‐29c‐3p and VEGF‐A levels predict the response to FOLFIRI plus aflibercept in elderly metastatic colorectal cancer patients
2025
·
Marta Toledano‐Fonseca
, María Teresa Cano‐Osuna
, et al.
·
European Journal of Clinical Investigation
PDF
Show more works
View as search
Works count:
37
Citation count:
460
H-index:
12
I10-index:
13
Year
Topic
Type